Kane Biotech Inc (KNE)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Kane Biotech Inc (KNE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010917
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develops human health products, animal health products, medical device coating and hard surface disinfectant. Kane Biotech also develops shampoos and skin care formulations for human skin infections including seborrheic dermatitis. The company caters its products to industrial, human and animal healthcare industries. It works in partnership with academic institutions to develop new technologies. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc (KNE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kane Biotech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kane Biotech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kane Biotech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kane Biotech Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Kane Biotech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kane Biotech Inc, Medical Equipment, Deal Details 10
Partnerships 10
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 10
Equity Offering 11
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 11
Kane Biotech Raises USD3 Million in Private Placement of Units 12
Kane Biotech Raises USD0.5 Million in First Tranche of Private Placement of Shares 13
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 14
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 15
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 16
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 17
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 19
Debt Offering 20
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 20
Kane Biotech Inc – Key Competitors 21
Kane Biotech Inc – Key Employees 22
Kane Biotech Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 14, 2017: Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options 24
Aug 16, 2017: Kane Biotech – Q2 2017 Financial Results 25
May 17, 2017: Kane Biotech – Q1 2017 Financial Reports 26
Corporate Communications 27
Sep 05, 2017: Kane Biotech Announces New Chief Financial Officer 27
Jun 05, 2016: Kane Biotech Announces Board Members 28
Jan 05, 2016: Kane Biotech appoints new CFO and announces addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Kane Biotech Inc, Medical Equipment, Key Facts, 2016 2
Kane Biotech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Kane Biotech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kane Biotech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kane Biotech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kane Biotech Inc, Deals By Market, 2011 to YTD 2017 8
Kane Biotech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 10
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 11
Kane Biotech Raises USD3 Million in Private Placement of Units 12
Kane Biotech Raises USD0.5 Million in First Tranche of Private Placement of Shares 13
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 14
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 15
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 16
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 17
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 19
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 20
Kane Biotech Inc, Key Competitors 21
Kane Biotech Inc, Key Employees 22

★海外企業調査レポート[Kane Biotech Inc (KNE)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nido Petroleum Ltd:企業の戦略的SWOT分析
    Nido Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • ConocoPhillips (COP):企業の財務・戦略的SWOT分析
    ConocoPhillips (COP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Allianz Seguros SA:企業の戦略・SWOT・財務分析
    Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report Summary Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Topas Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Topas Therapeutics GmbH (Topas Therapeutics) is a biotechnological company that designs and develops nanoparticle products loaded with antigenic peptides. The company’s pre-clinical pipeline categories are used in the treatment of allergies, immune mediated diseases, autoimmune diseases, and …
  • Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rockland Immunochemicals Inc (Rockland) is a biotechnology company that manufactures research tools for basic, applied and clinical research in functional genomics, drug discovery, gene therapy markets. The company’s products include collagen products, primary and secondary antibodies, Epi-P …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務情報
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Mitsubishi Logistics Corporation (9301):企業の財務・戦略的SWOT分析
    Mitsubishi Logistics Corporation (9301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • IHI Aerospace Co Ltd:企業の戦略・SWOT・財務情報
    IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report Summary IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Key Tronic Corp (KTCC):企業の財務・戦略的SWOT分析
    Summary Key Tronic Corp (Key Tronic) is an electronic manufacturing service provider that offers OEM manufacturing solutions. The company offers services such as product assembly, PCBA, PCBA rapid response center, molding, metal, tooling, program management, supply chain management, quality, testing …
  • Electronic Arts Inc.:企業の戦略・SWOT・財務分析
    Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UMW Holdings Bhd (UMW)
    UMW Holdings Bhd (UMW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Even Construtora E Incorporadora Sa:企業の戦略・SWOT・財務分析
    Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report Summary Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Esperion Therapeutics Inc (ESPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Kawasaki Kisen Kaisha, Ltd.:企業の戦略・SWOT・財務分析
    Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Depository Trust & Clearing Corporation:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Aerojet Rocketdyne Holdings Inc:企業の戦略・SWOT・財務情報
    Aerojet Rocketdyne Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Aerojet Rocketdyne Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Avadel Pharmaceuticals Plc (AVDL):医療機器:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆